- PacBio (PACB, Financial) joins the 1000 Genomes Long Read Sequencing Project, adding isoform sequencing capabilities.
- The project will sequence approximately 1,000 samples, yielding significant transcriptomic data for diverse human populations.
- Results and analysis will be publicly available, enhancing research reproducibility and innovation in genomics.
PacBio (PACB), a leading player in the life sciences sector, has announced its participation in the 1000 Genomes Long Read Sequencing Project. The company is set to contribute full-length isoform sequencing for around 1,000 samples, using its Kinnex RNA kits and Revio sequencing platform. This contribution aims to offer new insights at the transcript level across a globally diverse human population cohort.
Each sample is projected to yield approximately 10 million full-length transcript reads, underscoring the scalability and precision of PacBio's HiFi technology. The project, conducted in collaboration with the University of Washington and Johns Hopkins University, seeks to enrich the foundational resources of the 1000 Genomes initiative.
PacBio's involvement will support the development of an open-access RNA resource, aiming to enhance understanding of gene expression and regulatory elements across different populations. Early findings from the initiative are anticipated to be presented at the forthcoming American Society of Human Genetics (ASHG) conference.
The project's commitment to public data availability and transparency is expected to further innovation and tool development within the genomics community. PacBio's contribution positions its technology as a key component of vital genomic research infrastructure, potentially expanding market opportunities and fostering the adoption of sequencing solutions in both research and clinical settings.
